Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial (Q42008293)

From Wikidata

Revision as of 06:23, 9 July 2023 by KrBot (talk | contribs) (‎Set a claim value: title (P1476): Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

title

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

main subject

placebo

0 references

interferon alfa

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Di Bisceglie AM

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

Martin P

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

Kassianides C

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

Lisker-Melman M

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

Murray L

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

Waggoner J

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

Goodman Z

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

Banks SM

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

Hoofnagle JH

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

language of work or name

English

0 references

publication date

1 November 1989

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

published in

The New England Journal of Medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

volume

321

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

issue

22

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

page(s)

1506-1510

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

Identifiers

DOI

10.1056/NEJM198911303212204

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

PubMed publication ID

2509917

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2509917

retrieved

15 October 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42008293&oldid=1931705238"